PACS Group (NYSE:PACS) Research Coverage Started at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of PACS Group (NYSE:PACS) in a research note released on Monday, MarketBeat Ratings reports. The brokerage issued an overweight rating and a $27.00 price target on the stock.

Other analysts also recently issued research reports about the stock. Royal Bank of Canada started coverage on shares of PACS Group in a research report on Monday. They set an outperform rating and a $30.00 price objective for the company. Oppenheimer started coverage on shares of PACS Group in a research note on Monday. They issued an outperform rating and a $31.00 price objective for the company. Citigroup started coverage on PACS Group in a research report on Monday. They set a buy rating and a $32.00 target price on the stock. Finally, Truist Financial began coverage on PACS Group in a research report on Monday. They issued a buy rating and a $32.00 target price for the company. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of Buy and an average target price of $30.50.

PACS Group Stock Performance

Shares of NYSE PACS opened at $24.67 on Monday. PACS Group has a fifty-two week low of $22.61 and a fifty-two week high of $25.72.

Insider Buying and Selling

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of the stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the completion of the sale, the chief executive officer now directly owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.